Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-009594)

Filing Details

Accession Number:: 0001209191-12-009594
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2012-02-13 17:37:16
Reporting Period:: 2011-12-31

Filing Date:: 2012-02-13
Accepted Time:: 2012-02-13 17:37:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1347178	Vanda Pharmaceuticals Inc.	VNDA	Pharmaceutical Preparations (2834)	030491827

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1454240	Joseph John Feeney	9605 Medical Center Drive Suite 300 Rockville MD 20850	Svp & Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-18	7,500	$0.00	7,500	No	5	M	Direct
Common Stock	Disposition	2011-02-18	2,985	$7.25	4,515	No	5	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	M	Direct
No	5	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2011-02-18	7,500	$0.00	7,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,500			No	5	M	Direct

Footnotes

Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
N/A